Public Health
Volume 122, Issue 1 , Pages 70-78 , January 2008

Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver

  • Nadia Fairbairn

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146
    • ,
  • Evan Wood

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146
    • Department of Medecine, University of British Columbia, 608-1081 Burrard Street, Vancouver, BC, Canada, V6Z 146
    • ,
  • Jo-anne Stoltz

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146
    • ,
  • Kathy Li

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146
    • ,
  • Julio Montaner

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146
    • Department of Medecine, University of British Columbia, 608-1081 Burrard Street, Vancouver, BC, Canada, V6Z 146
    • ,
  • Thomas Kerr

      Affiliations

    • British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146
    • Department of Medecine, University of British Columbia, 608-1081 Burrard Street, Vancouver, BC, Canada, V6Z 146
    • Corresponding Author InformationCorresponding author. Tel.: +16048069116.

Received 7 November 2005 ,Revised 7 September 2006 ,Accepted 23 February 2007.

References 

  1. Palepu A, Tyndall MW, Leon H, Muller J, O’Shaughnessy MV, Schechter MT, et al. Hospital utilization and costs in a cohort of injection drug users. Can Med Assoc J. 2001;165:415–420
  2. Wood E, Tyndall M, Spittal P. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy. 2002;13:95–102
  3. Wall R, Rehm J, Fischer B, Brands B, Gliksman L, Stewart J, et al. Social costs of untreated opioid dependence. J Urban Health. 2000;77:688–722
  4. Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97:39–47
  5. Tyndall MW, Craib KJ, Currie S, Li K, O’Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. JAIDS. 2001;28:351–357
  6. Perucci CA, Davoli M, Rapiti E, Abeni DD, Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991;81:1307–1310
  7. Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96:1113–1125
  8. Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction. 2002;97:963–967
  9. Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48:135–141
  10. Darke S, Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health. 2003;80:189–200
  11. Fischer B, Rehm J, Blitz-Miller T. Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time. Can Med Assoc J. 2000;162:1709–1713
  12. Fischer B, Brissette S, Brochu S, Bruneau J, el-Guebaly N, Noel L, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Can Med Assoc J. 2004;171:235–239
  13. Kerr T, Wood E, Grafstein E, Ishida T, Shannon K, Lai C, et al. High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health. 2005;27:62–66
  14. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O’Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887–893
  15. Darke S, Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992–1996. Addiction. 2000;95:569–573
  16. Ruttenber AJ, Kalter HD, Santinga P. The role of ethanol abuse in the etiology of heroin-related death. J Forensic Sci. 1990;35:891–900
  17. Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend. 2005;80:329–335
  18. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs. 2000;32:137–141
  19. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?. Can Med Assoc J. 2001;165:405–410
  20. Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Can Med Assoc J. 2003;168:19–24
  21. Bennett GA, Higgins DS. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94:1179–1189
  22. Farrell G, Thorne J. Where have all the flowers gone? Evaluation of the Taliban crackdown against opium poppy cultivation in Afghanistan. Int J Drug Policy. 2005;16:81–91
  23. British Columbia Coroners Service. Illicit drug deaths: 1997–2004. Ministry of Public Safety and Attorney General, 2006.
  24. Glittenberg J, Anderson C. Methamphetamines: use and trafficking in the Tucson–Nogales area. Subst Use Misuse. 1999;34:1977–1989
  25. Urbina A, Jones K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis. 2004;38:890–894
  26. Bryant WK, Galea S, Tracy M, Markham Piper T, Tardiff KJ, Vlahov D. Overdose deaths attributed to methadone and heroin in New York City, 1990–1998. Addiction. 2004;99:846–854
  27. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590
  28. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94:961–972
  29. Gouny P, Gaitz JP, Vayssairat M. Acute hand ischemia secondary to intraarterial buprenorphine injection: treatment with iloprost and dextran-40: a case report. Angiology. 1999;50:605–606
  30. Kintz P. A new series of 13 buprenorphine-related deaths. Clin Biochem. 2002;35:513–516
  31. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int. 2001;121:65–69
  32. Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction. 1999;94:71–82
  33. Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992–1996. Drug Alcohol Depend. 2000;60:141–150
  34. Harlow KC. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976–87. Public Health Report. 1990;105:455–462
  35. Ruttenber AJ, Luke JL. Heroin-related deaths: new epidemiologic insights. Science. 1984;226:14–20
  36. Seal KH, Kral AH, Gee L, Moore LD, Bluthenthal RN, Lorvick J, et al. Predictors and prevention of non-fatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91:1842–1846
  37. Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26:453–460
  38. Braitstein P, Li K, Tyndall M, Spittal P, O’Shaughnessy MV, Schilder A, et al. Sexual violence among a cohort of injection drug users. Soc Sci Med. 2003;57:561–569
  39. Kuyper LM, Lampinen TM, Li K, Spittal PM, Hogg RS, Schechter MT, et al. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect. 2004;80:531–535
  40. Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, et al. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care. 2003;15:187–195
  41. Brugal MT, Barrio G, De LF, Regidor E, Royuela L, Suelves JM. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction. 2002;97:319–327
  42. Tobin KE, Davey MA, Latkin CA. Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates. Addiction. 2005;100:397–404
  43. Dovey K, Fitzgerald J, Choi Y. Safety becomes danger: dilemmas of drug-use in public space. Health Place. 2001;7:319–331
  44. Bundesministerium fur Gesundheit und Soziale Sicherung, editor. Evaluation der Arbeit von Drogenkonsumauen in der Bundesrepulik Deutschland. Baden-Baden: Nomos; 2003.
  45. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction. 1996;91:413–417
  46. Davoli M, Perucci CA, Forastiere F, Doyle P, Rapiti E, Zaccarelli M, et al. Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users. Int J Epidemiol. 1993;22:273–277
  47. van Ameijden EJ, Langendam MW, Coutinho RA. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addict Behav. 1999;24:559–563
  48. Patterson TL, Semple SJ, Zians JK, Strathdee SA. Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use. J Urban Health. 2005;82:120–126
  49. Darke S, Zador D. Fatal heroin ‘overdose’: a review. Addiction. 1997;91:1765–1772
  50. Moore D. Governing street-based injecting drug users: a critique of heroin overdose prevention in Australia. Soc Sci Med. 2004;59:1547–1557
  51. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. Br Med J. 1996;312:1435–1436
  52. Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health. 2003;80:291–301

PII: S0033-3506(07)00085-6

doi: 10.1016/j.puhe.2007.02.016

Public Health
Volume 122, Issue 1 , Pages 70-78 , January 2008

Article Tools